Mission Statement:

To improve the care and outcomes of kidney disease
patients worldwide through promoting coordination,
collaboration and integration of initiatives to develop
and implement clinical practice guidelines.

Home

Treatment of Infection of the Vascular Access - General

Guideline Organization

Recommendation (Evidence Level)

Evidence

Comments

CARI-Australia

 

 

 

CSN-Canada

 

 

 

EBPG-Europe
November 2002

- Two separate blood cultures from a peripheral vein before start antibiotics for all access related infection (Level A)
- Methicillin first choice. Glycopeptide recommended in hospitals and countries with increased incidence of MRSA and in known MRSA carriers (Level B)
- Additional coverage for gram negatives including pseudomonas with third or fourth generation cephalosporins in severely ill and immunocompromised patients (Level B)

Guideline VI.4  Treatment of vascular access infection

 

KDOQI-US

 

 

 

UK-Guidelines

 - All HD units should collect and audit data on the form of vascular access in use in incident and prevalent haemodialysis patients and the rates of bacteraemia per 1000 patient days using central venous catheters, arterio-venous grafts and arterio-venous fistulae.

 Module 3a: Haemodialysis- 7.0 Vascular Access